Tersavia
About
What does Tersavia do?
Theravia is an international pharmaceutical company focused on developing and commercializing cutting-edge treatments for patients with rare and debilitating conditions. The company has a portfolio of marketed products and an R&D pipeline in areas such as fertility, allergy, and skin disorders. Theravia was formed through the merger of Addmedica and CTRS in 2023.
What industry does Tersavia operate in?
Tersavia operates in Rare Disease, Pharmaceuticals, Biotechnology, Drug Discovery, Specialty Pharmaceuticals.
AI-powered platform accelerating biological research and drug discovery.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
Manufacturer, packager, and distributor of private-label over-the-counter pharmaceutical and consumer healthcare products.
An entrant is a company tagged Pharmaceuticals whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.